Wall Street's on edge. These are the levels that stocks must not violate, says Fundstrat

Amid recent market pressure, with the Nasdaq Composite down 2.3%, analysts offer mixed outlooks. While Citi's 'When Generals Fail' indicator suggests continued long-term strength for big tech, Fundstrat's Mark Newton warns of deteriorating market breadth in the Russell 3000, a signal that historically preceded market corrections. Newton identifies critical support levels for the S&P 500 (6,631) and Nasdaq 100 (599), stating their violation would indicate further near-term volatility, though he still anticipates a potential December bounce and views Nvidia's upcoming earnings as a key catalyst.

Analysis

The market is currently experiencing pressure, with the Nasdaq Composite declining 2.3% in its worst session in over a month, driven by concerns over rich valuations and a potentially slower pace of Federal Reserve interest rate cuts. Technical indicators present a mixed outlook; Citi's "When Generals Fail" indicator, focusing on the Mag 7, remains supportive for the broader market, with only Meta trading below its 200-day moving average.

Conversely, Fundstrat's Mark Newton highlights deteriorating market breadth, noting that the percentage of Russell 3000 stocks within 20% of 12-month highs has rolled over to approximately 50%, a condition that historically preceded the 2022 market peak. Newton identifies critical support levels for the S&P 500 at 6,631 and the Nasdaq 100 proxy ETF at 599, emphasizing that a violation of these levels would signal further near-term volatility.

Despite these technical warnings, Newton still anticipates a potential December bounce and views Nvidia's (NVDA) upcoming earnings on November 19 as a key positive catalyst, provided its numbers are well-received. He also suggests that subdued sentiment could present a compelling case for buying dips during this seasonally favorable period, though he cautions against expecting an immediate return to new highs.

Broader financial conditions are seen as supportive by Strategas, noting no meaningful stress in credit markets, with global distressed debt totaling a modest $500 billion against a $300 trillion global market. Corporate activity includes Merck's nearing $9.2 billion acquisition of Cidara Therapeutics and Applied Materials' shares declining despite strong sales forecasts driven by AI demand.

Key Decisions for Investors

• Monitor the critical support levels of 6,631 for the S&P 500 and 599 for the Nasdaq 100 proxy ETF, as their violation would indicate further near-term volatility
• Evaluate Nvidia's (NVDA) upcoming earnings on November 19 as a potential market catalyst, noting its $178.91 support level for near-term bearish sentiment
• Consider tactical buying on dips, especially in Mag 7 components, given subdued sentiment and Citi's supportive long-term indicator, but remain vigilant regarding the deteriorating market breadth highlighted by Fundstrat